Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Prague Clinical Services (PCS) is an independent contract research organization (CRO) headquartered in Prague, Czech Republic. It is a leading clinical research service provider in Central and Eastern Europe, with a core team holding over 20 years of experience in the pharmaceutical industry and clinical research. Its client base spans multiple regions across Europe, North America, and Asia.
PCS offers end-to-end services covering the full spectrum of clinical development for drugs from Phase I to IV, and the complete process of clinical research for medical devices. Its full-chain outsourced services specifically include feasibility studies and site selection, project management, study monitoring, logistics and warehousing management for drugs and study supplies, regulatory and ethics committee submission, scientific consulting for European and North American markets, marketing application support, medical writing, data management, biostatistics, quality assurance, pharmacovigilance, and more. It also runs pharmaceutical-related training programs to help clients advance the research and development of new drugs and medical devices. All services strictly follow European GCP standards, with an in-house QA department and a continuously updated standard operating system, delivering strong quality control.
PCS does not publicly disclose a standardized pricing schedule on its official website. All service quotes are customized based on project scale and specific client needs. The website is currently directly accessible to users in China, no VPN proxy is required.
Its strengths include strong regional coverage, a deeply experienced team, and a comprehensive compliance system, enabling it to deliver one-stop clinical research solutions. Its drawbacks are the lack of public pricing and no Chinese-language interface, which creates certain inconveniences for domestic Chinese clients when coordinating projects. This service is best suited for global pharmaceutical companies and medical device R&D enterprises that plan to expand into the Central and Eastern European clinical research market.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on pragueclinicalservices.com official site.
pragueclinicalservices.com is an Czechia Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach pragueclinicalservices.com directly.